History Repeats: From 1970s Public Offering to Modern Revival
This is not Medline’s first foray into the public market. The company initially went public in 1972, only to go private again in 1977. Decades later, it became one of the most significant leveraged buyouts in history when Blackstone and its partners acquired Medline for over $30 billion in 2021.
If the new IPO proceeds as planned, Medline intends to list shares on the Nasdaq Global Select Market under the ticker symbol “MDLN.”
Legal and Financial Powerhouses Behind the Deal
Medline’s legal team from Simpson Thacher & Bartlett LLP includes Joshua Ford Bonnie, Jonathan R. Ozner, and Katharine L. Thompson.
The underwriters, represented by Latham & Watkins LLP, include Jason M. Licht, Patrick H. Shannon, and Cathy A. Birkeland.
Leading the underwriting syndicate are Goldman Sachs & Co., Morgan Stanley, BofA Securities, and J.P. Morgan, serving as lead book-running managers for what could become the largest healthcare IPO of the decade.
